Workflow
Zheng Quan Zhi Xing
icon
Search documents
科华生物: 中信证券股份有限公司关于上海科华生物工程股份有限公司可转换公司债券回售有关事项的核查意见
Zheng Quan Zhi Xing· 2025-09-07 08:17
Group 1 - The core viewpoint of the article is the verification opinion of CITIC Securities regarding the repurchase of convertible bonds issued by Shanghai Kehua Bio-engineering Co., Ltd. [1][7] - The issuance of Kehua convertible bonds was approved by the China Securities Regulatory Commission, with a total amount of 738 million yuan, and began trading on August 20, 2020 [1][2] - The conversion period for the bonds started on February 3, 2021, and will last until the maturity date on July 27, 2026 [2] Group 2 - The conditional repurchase clause allows bondholders to sell their bonds back to the company if the stock price falls below 70% of the conversion price for 30 consecutive trading days during the last two interest years [2][3] - The conversion price is set at 20.64 yuan per share, and the repurchase price will be the face value plus accrued interest [3][4] - The accrued interest for the sixth interest year is calculated to be 0.241 yuan per bond, resulting in a total repurchase price of 100.241 yuan per bond [5] Group 3 - The repurchase rights are not mandatory, allowing bondholders to choose whether to exercise their right to sell back the bonds [5][6] - The announcement period for the repurchase will begin the trading day after the conditions are met, with daily reminders until the end of the repurchase period [6] - The repurchase period for bondholders to submit their requests is from September 10 to September 16, 2025 [6] Group 4 - The company will continue trading the convertible bonds during the repurchase period but will suspend conversion rights [6] - CITIC Securities has confirmed that the repurchase matters comply with relevant regulations and the terms outlined in the offering prospectus [7]
科华生物: 北京市金杜(广州)律师事务所关于上海科华生物工程股份有限公司可转换公司债券回售的法律意见书
Zheng Quan Zhi Xing· 2025-09-07 08:17
Core Viewpoint - The legal opinion letter issued by King & Wood Mallesons confirms that Shanghai Kehua Bio-engineering Co., Ltd. can proceed with the repurchase of its convertible bonds under specific conditions outlined in the relevant regulations and the offering prospectus [1][9]. Group 1: Legal Framework and Compliance - The legal opinion is based on the Company Law, Securities Law, and relevant regulations, ensuring that the facts presented are true, accurate, and complete [2][3]. - King & Wood Mallesons has conducted thorough verification of the documents related to the bond repurchase, ensuring compliance with legal standards [2][3]. Group 2: Convertible Bond Issuance and Approval - The company received approval from the China Securities Regulatory Commission (CSRC) to issue convertible bonds totaling 738 million yuan, with a maturity of six years [6][7]. - The bonds were listed on the Shenzhen Stock Exchange on August 20, 2020, under the name "Kehua Convertible Bonds" [7]. Group 3: Repurchase Conditions - The offering prospectus stipulates that bondholders can sell their bonds back to the company if the stock price falls below 70% of the conversion price for 30 consecutive trading days during the last two interest periods [8][9]. - The company’s stock price was below the specified threshold of 14.45 yuan per share for the required period, thus triggering the repurchase conditions [8][9]. Group 4: Conclusion and Recommendations - The legal opinion concludes that the company can repurchase the convertible bonds as per the established conditions, provided that the repurchase announcement and results are properly disclosed [9].
方邦股份: 广东信达律师事务所关于广州方邦电子股份有限公司2024年限制性股票激励计划预留授予相关事项的法律意见书
Zheng Quan Zhi Xing· 2025-09-07 08:17
法律意见书 关于广州方邦电子股份有限公司 中国 深圳 福田区 益田路6001号太平金融大厦11、12楼 邮 政编码:518038 电话(Tel.):(0755) 8826 5288 传真(Fax.):(0755) 8826 5537 网址(Website):www.sundiallawfirm.com 法律意见书 广东信达律师事务所 广东信达律师事务所 关于广州方邦电子股份有限公司 法律意见书 信达励字(2025)第129号 致:广州方邦电子股份有限公司 根据广州方邦电子股份有限公司(以下简称"公司")与广东信达律师事务 所(以下简称"信达")签订的专项法律顾问协议,信达接受公司的委托担任公 司实施2024年限制性股票激励计划(以下简称"2024年激励计划")的特聘专项 法律顾问,就公司2024年激励计划预留授予相关事项(以下简称"本次授予") 相关事项出具《广东信达律师事务所关于广州方邦电子股份有限公司2024年限制 性股票激励计划预留授予相关事项的法律意见书》 (以下简称"《法律意见书》")。 信达是在中华人民共和国合法注册并具有中华人民共和国法律执业资格的 律师事务所,有资格依据中华人民共和国有关法律、 ...
申能股份: 申能股份有限公司股权激励限制性股票回购注销实施公告
Zheng Quan Zhi Xing· 2025-09-07 08:17
Core Viewpoint - The company plans to repurchase and cancel 15,300 restricted stocks due to the departure of one incentive target during the effective period of the stock incentive plan [1][2] Group 1: Repurchase and Cancellation Details - The repurchase is based on the company's A-share restricted stock incentive plan, which allows for the cancellation of stocks when an incentive target leaves [1] - The repurchase price is set at 1.68 yuan per share, and the total number of shares to be canceled is 15,300 [1] - Following the cancellation, the company's total share capital will decrease from 4,894,094,676 shares to 4,894,079,376 shares [1] Group 2: Decision Process and Legal Compliance - The board of directors was authorized by the shareholders' meeting to handle matters related to the stock incentive plan, including the repurchase and cancellation of restricted stocks [1] - The company has complied with all necessary legal procedures and disclosures, including obtaining a legal opinion from Shanghai Jintiancheng Law Firm confirming the legality of the repurchase [1][2] - The company assures that the repurchase will not adversely affect the stability of the management team or the company's financial performance [1]
科华生物: 联合资信评估股份有限公司关于上海科华生物工程股份有限公司2025年半年度亏损的关注公告
Zheng Quan Zhi Xing· 2025-09-07 08:17
联合〔2025〕9130 号 联合资信评估股份有限公司关于上海科华生物工程股份有限公司 受上海科华生物工程股份有限公司(以下简称"公司")委托,联合资信评估股份有限公司(以 下简称"联合资信")对公司及其发行的相关债项进行了信用评级。除评级委托关系外,联合资信、 评级人员与公司不存在任何影响评级行为独立、客观、公正的关联关系。 根据联合资信最近的评级结果,公司个体信用等级为 a+,公司主体长期信用等级为 A+,评级展 望为稳定;公司委托联合资信评级的相关债项评级结果详见下表,评级有效期为相关债项存续期。 表1 截至本公告出具日公司委托联合资信进行信用评级的存续期内公开发行债券情况 债券代码 债券简称 上次主体评级结果 上次债项评级结果 上次评级时 间 债券余额 兑付日 A /稳定 + A /稳定 2025 年 6 月 26 日 2.25 亿元 2026/07/28 资料来源:公开资料,联合资信整理 根据公司 2025 年 8 月 27 日披露的《上海科华生物工程股份有限公司 2025 年半年度报告》, 年同期下降 209.76%。 公司亏损原因包括:(1)随着行业集采政策持续推进,DRG 快速落地、检验结果互 ...
青木科技: 兴业证券股份有限公司关于青木科技股份有限公司首次公开发行前已发行股份上市流通的核查意见
Zheng Quan Zhi Xing· 2025-09-07 08:17
Group 1 - The core viewpoint of the article is the verification opinion of the sponsor regarding the listing and circulation of shares prior to the initial public offering of Qiangmu Technology Co., Ltd. [1] - Qiangmu Technology has issued 16,666,667 shares in its initial public offering, resulting in a total share capital of 66,666,667 shares, with 51,475,416 shares subject to restrictions, accounting for 77.21% of the total [1] - The company plans to implement a profit distribution and capital reserve conversion plan, which will adjust the total share capital to 92,535,333 shares after the cancellation of 570,000 repurchased shares [2] Group 2 - Three shareholders, including Mr. Lü Bin and Mr. Lu Bin, have made commitments regarding the lock-up period of their shares, which lasts for 36 months from the listing date [3][4] - The shareholders' lock-up period will automatically extend by six months if the stock price falls below the initial offering price for a specified duration [7] - The total number of shares eligible for circulation after the lifting of restrictions is 16,826,250 shares, representing 18.18% of the company's total share capital [8][10] Group 3 - The company has confirmed that the shareholders have adhered to their commitments regarding the lock-up period and have not engaged in any violations [8] - The sponsor has verified that the lifting of the lock-up on shares complies with relevant laws and regulations, and the shareholders must continue to fulfill their commitments regarding share reductions [11]
方邦股份: 关于向2024年限制性股票激励计划激励对象授予预留部分限制性股票的公告
Zheng Quan Zhi Xing· 2025-09-07 08:17
证券代码:688020 证券简称:方邦股份 公告编号:2025-055 广州方邦电子股份有限公司 关于向 2024 年限制性股票激励计划激励对象授予预 留部分限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 限制性股票预留授予日:2025 年 9 月 5 日 ? 限制性股票预留授予数量:49 万股,约占公司目前股本总额 81,348,500 股的 0.60%; ? 限制性股票预留授予价格:25.7532 元/股 ? 股权激励方式:第二类限制性股票 《广州方邦电子股份有限公司 2024 年限制性股票激励计划(草案)》(以 下简称"《激励计划》"或"本激励计划")规定的 2024 年限制性股票预留授 予条件已经成就,根据广州方邦电子股份有限公司(以下简称"公司")2024 年第三次临时股东大会的授权,公司于 2025 年 9 月 5 日召开第四届董事会第八 次会议、第四届监事会第七次会议,审议通过了《关于向 2024 年限制性股票激 励计划激励对象授予预留部分限制性股票的议案》,同意以 20 ...
方邦股份: 监事会关于公司2024年限制性股票激励计划预留授予激励对象名单的核查意见(截至授予日)
Zheng Quan Zhi Xing· 2025-09-07 08:17
广州方邦电子股份有限公司监事会 关于公司 2024 年限制性股票激励计划 预留授予激励对象名单的核查意见(截至授予日) 广州方邦电子股份有限公司(以下简称"公司") 监事会依据《中华人民共 和国公司法》 (以下简称" 《公司法》")、 《中华人民共和国证券法》 (以下简称"《证 券法》")、 《上市公司股权激励管理办法》 (以下简称" 《管理办法》")、 《上海证券 交易所科创板股票上市规则》 (以下简称"《上市规则》")、 《科创板上市公司自律 监管指南第 4 号——股权激励信息披露》 (6)中国证监会认定的其他情形。 法律、法规及规范性文件和《广州方邦电子股份有限公司章程》 (以下简称"《公 司章程》")的有关规定,对公司 2024 年限制性股票激励计划(以下简称"本激 励计划")预留授予激励对象名单(预留授予日)进行了核查,现发表核查意见 如下: 得成为激励对象的情形: (1)最近 12 个月内被证券交易所认定为不适当人选; (2)最近 12 个月内被中国证监会及其派出机构认定为不适当人选; (3)最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政处 罚或者采取市场禁入措施; (4)具有《 ...
方邦股份: 2024年限制性股票激励计划预留授予激励对象名单(截至授予日)
Zheng Quan Zhi Xing· 2025-09-07 08:17
广州方邦电子股份有限公司 (截至授予日) 一、限制性股票激励计划的分配情况 获授予的限制 占授予限制 占本次授予时公司 序号 姓名 国籍 职务 性股票数量(万 性股票总数 股本总额的比例 股) 的比例 一、董事、高级管理人员、核心技术人员 二、其他激励对象 核心技术/业务骨干(34 人) 49 18.28% 0.60% 预留部分合计 49 18.28% 0.60% 注:1、本激励计划中部分合计数与各明细数相加之和在尾数上如有差异,系以上百分 比结果四舍五入所致,下同。 过公司股本总额的 1.00%。公司全部有效期内股权激励计划所涉及的标的股票总数累计未超 过公司股本总额的 20.00%。预留权益比例未超过本激励计划拟授予权益数量的 20.00%。激 励对象因个人原因自愿放弃获授权益的,由董事会对授予数量作相应调整,将激励对象放弃 的权益份额调减或调整到预留部分或在激励对象之间进行分配。 广州方邦电子股份有限公司 董事会 ...
卓易信息: 江苏卓易信息科技股份有限公司控股股东、实际控制人减持股份计划公告
Zheng Quan Zhi Xing· 2025-09-07 08:17
证券代码:688258 证券简称:卓易信息 公告编号:2025-033 江苏卓易信息科技股份有限公司 控股股东、实际控制人减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示: ? 股东持有股份的基本情况 截至本公告披露日,江苏卓易信息科技股份有限公司(以下简称"卓易信息" 或"公司")控股股东、实际控制人、董事长兼总经理谢乾先生直接持有公司股 份 47,667,923 股,占公司股份总数的 39.35%。上述股份来源于公司首次公开发 行前持有的股份及公司转增股份。 ? 减持计划的主要内容 因自身资金需求,谢乾先生拟通过集中竞价和大宗交易相结合的方式减持不 超过 3,634,267 股公司股份,占公司股份总数比例不超过 3.00%,将于本减持计 划公告披露之日起 15 个交易日后的 3 个月内进行。其中:拟通过集中竞价方式 减持的,任意连续 90 日内减持总数不超过公司股份总数的 1%;拟通过大宗交易 方式减持的,任意连续 90 日内减持总数不超过公司股份总数的 2%。若在减持计 划实 ...